Q1 2025 Holdings
Filed 2025-05-15 | 21 holdings | $229.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Bristol-Myers Squibb Co(BMY) | COM | 110122108 | $18.0M | 295,000 | 7.8% |
| Amgen Inc(AMGN) | COM | 031162100 | $15.6M | 50,000 | 6.8% |
| Biogen Inc(BIIB) | COM | 09062X103 | $15.5M | 113,500 | 6.8% |
| ELI Lilly & Co(LLY) | COM | 532457108 | $14.9M | 18,000 | 6.5% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $14.2M | 186,384 | 6.2% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $13.7M | 379,303 | 6.0% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $13.5M | 390,644 | 5.9% |
| Perrigo Co PLC(PRGO) | SHS | G97822103 | $13.4M | 479,517 | 5.9% |
| Roivant Sciences LTD(ROIV) | SHS | G76279101 | $13.1M | 1,300,000 | 5.7% |
| Teva Pharmaceutical Inds LTD(TEVA) | SPONSORED ADS | 881624209 | $12.3M | 801,806 | 5.4% |
| Royalty Pharma PLC(RPRX) | SHS CLASS A | G7709Q104 | $11.1M | 356,894 | 4.8% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $10.5M | 205,000 | 4.6% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $10.2M | 160,000 | 4.4% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $7.9M | 24,000 | 3.5% |
| Summit Therapeutics Inc(SMMT) | COM | 86627T108 | $7.7M | 400,000 | 3.4% |
| Halozyme Therapeutics Inc(HALO) | COM | 40637H109 | $7.7M | 120,000 | 3.3% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $7.0M | 175,000 | 3.1% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $6.9M | 235,350 | 3.0% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $6.0M | 418,127 | 2.6% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $5.7M | 731,818 | 2.5% |
| Newamsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $4.5M | 221,152 | 2.0% |